Dynamic Contrast-Enhanced MRI Reveals Unique Blood-Brain Barrier Permeability Characteristics in the Hippocampus in the Normal Brain

References

1. 1.↵
   2. Bartels AL,
   3. Kortekaas R,
   4. Bart J, et al

   . Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging 2009;30:1818–24 doi:10.1016/j.neurobiolaging.2008.02.002 pmid:18358568

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Loeffler C,
   3. Dietz K,
   4. Schleich A, et al

   . Immune surveillance of the normal human CNS takes place in dependence of the locoregional blood-brain barrier configuration and is mainly performed by CD3(+)/CD8(+) lymphocytes. Neuropathology 2011;31:230–38 doi:10.1111/j.1440-1789.2010.01167.x pmid:21092063

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Jeneson A,
   3. Squire LR

   . Working memory, long-term memory, and medial temporal lobe function. Learn Mem 2012;19:15–25 doi:10.1101/lm.024018.111 pmid:22180053

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Tatu L,
   3. Vuillier F

   . Structure and vascularization of the human hippocampus. Front Neurol Neurosci 2014;34:18–25 doi:10.1159/000356440 pmid:24777127

   CrossRefPubMed
5. 5.↵
   2. Mackay M,
   3. Tang CC,
   4. Volpe BT, et al

   . Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus. Lupus Sci Med 2015;2:e000074 doi:10.1136/lupus-2014-000074 pmid:25861456

   Abstract/FREE Full Text
6. 6.↵
   2. Ueno M,
   3. Chiba Y,
   4. Murakami R, et al

   . Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions. Brain Tumor Pathol 2016;33:89–96 doi:10.1007/s10014-016-0255-7 pmid:26920424

   CrossRefPubMed
7. 7.↵
   2. Weidman EK,
   3. Foley CP,
   4. Kallas O, et al

   . Evaluating permeability surface-area product as a measure of blood-brain barrier permeability in a murine model. AJNR Am J Neuroradiol 2016;37:1267–74 doi:10.3174/ajnr.A4712 pmid:26965465

   Abstract/FREE Full Text
8. 8.↵
   2. Sanelli PC,
   3. Ugorec I,
   4. Johnson CE, et al

   . Using quantitative CT perfusion for evaluation of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2011;32:2047–53 doi:10.3174/ajnr.A2693 pmid:21960495

   Abstract/FREE Full Text
9. 9.↵
   2. Cuenod CA,
   3. Balvay D

   . Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging 2013;94:1187–204 doi:10.1016/j.diii.2013.10.010 pmid:24211260

   CrossRefPubMed
10. 10.↵
    2. Sanelli PC,
    3. Jacobs MA,
    4. Ougorets I, et al

    . Posterior reversible encephalopathy syndrome on computed tomography perfusion in a patient on “Triple H” therapy. Neurocrit Care 2005;3:46–50 doi:10.1385/NCC:3:1:046 pmid:16159094

    CrossRefPubMed
11. 11.↵
    2. Hyman BT,
    3. Van Hoesen GW,
    4. Damasio AR, et al

    . Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168–70 doi:10.1126/science.6474172 pmid:6474172

    Abstract/FREE Full Text
12. 12.↵
    2. Wang X,
    3. Pal R,
    4. Chen XW, et al

    . High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Brain Res Mol Brain Res 2005;140:120–26 doi:10.1016/j.molbrainres.2005.07.018 pmid:16137784

    CrossRefPubMed
13. 13.↵
    2. Olsson T,
    3. Wieloch T,
    4. Smith ML

    . Brain damage in a mouse model of global cerebral ischemia. Effect of NMDA receptor blockade. Brain Res 2003;982:260–69 doi:10.1016/S0006-8993(03)03014-2 pmid:12915260

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Bartsch T,
    3. Döhring J,
    4. Reuter S, et al

    . Selective neuronal vulnerability of human hippocampal CA1 neurons: lesion evolution, temporal course, and pattern of hippocampal damage in diffusion-weighted MR imaging. J Cereb Blood Flow Metab 2015;35:1836–45 doi:10.1038/jcbfm.2015.137 pmid:26082014

    CrossRefPubMed
15. 15.↵
    2. Wang X,
    3. Michaelis EK

    . Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2010;2:12 doi:10.3389/fnagi.2010.00012 pmid:20552050

    CrossRefPubMed
16. 16.↵
    2. Montagne A,
    3. Barnes SR,
    4. Sweeney MD, et al

    . Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015;85:296–302 doi:10.1016/j.neuron.2014.12.032 pmid:25611508

    CrossRefPubMed
17. 17.↵
    2. Dorr A,
    3. Sahota B,
    4. Chinta LV, et al

    . Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 2012;135:3039–50 doi:10.1093/brain/aws243 pmid:23065792

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Gulinello M,
    3. Wen J,
    4. Putterman C

    . Neuropsychiatric symptoms in lupus. Psychiatr Ann 2012;42:322–28 doi:10.3928/00485713-20120906-05 pmid:25620816

    CrossRefPubMed
19. 19.↵
    2. Lauvsnes MB,
    3. Beyer MK,
    4. Kvaloy JT, et al

    . Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Arthritis Rheumatol 2014;66:3387–94 doi:10.1002/art.38852 pmid:25156222

    CrossRefPubMed